Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
COSCIENS Biopharma Inc
T.CSCI
Alternate Symbol(s):
CSCI
Healthcare
Biotechnology
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone...
deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CSCI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Next
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 15, 2024 7:54pm
Copilot: Insulin Tolerance Test(ITT) vs. CSCI's Test:
Insulin Tolerance Test (ITT) Procedure: ITT involves administering insulin to induce hypoglycemia (low blood sugar). This triggers the release of growth hormone, which is then measured
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 15, 2024 7:59am
"Live long and prosper" oat chewy
CSCI could get Jennifer Aniston to use her Aveeno association to sell its oat chewy products. Aveeno inside! It could get the world's oldest family who swears by oats to endorse the product. CSCI
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 15, 2024 7:13am
Pepsico scientist and comprehensive study of oats
Review Crit Rev Food Sci Nutr
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Aug 14, 2024 2:19pm
RE:Concerns with Quarterly
Hopeforthebest: "Reduced sales totals for PGX". LOL!
(167)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Post by
Hopeforthebest
on Aug 14, 2024 11:34am
Concerns with Quarterly
Only had the opportunity to briefly review the quarterly report and a few things really concerned me. The amount of cash the merged company is eating through Reduced sales totals for PGX Cost of
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 14, 2024 11:31am
Pediatric Diagnostic Test
The test was approved for the adult market by the US FDA and in Europe and licensed for significant upfront money. In July 2023 AEZS expected it would sign a new North American deal based on its
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Aug 14, 2024 7:22am
RE:wainwright does not follow cosciens
Perplexity Ai "HC Wainwright's last target price for Aeterna Zentaris was set at $15.00 on November 13, 2023." November 13, 2023 was about 1 month before the announcement of the
...more
(2244)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Aug 14, 2024 2:11am
wainwright does not follow cosciens
https://hcwco.com/services/research/coverage-universe/#healthcare
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 13, 2024 3:34pm
Diagnostic
Could CSCI get a milestone payment for the pediatric diagnostic from existing licensees in the near future? How aggressivly have they marketed the product to date without the ability to sell to
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 13, 2024 3:28pm
Assorted programs
"We are evaluating the data obtained to date and considering our plans for the treatment of NMOSD using an AIM Biologicals platform." "We are currently continuing in-vitro
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 13, 2024 3:23pm
Avenanthramide pill
"The Company expects to initiate the MAD arm during Q3, the summer 2024."
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 13, 2024 3:16pm
Avenanthramide chewy
They've now got an avenanthramide chewy product for exercise inflammation, etc. The also mention they've demonstrated the yeast beta glucan in vitro and in vivo. Last November they said they
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Aug 13, 2024 2:39pm
RE:RE:RE:RE:RE:New Press Release - COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results
The merger wasn't completed until Jun. 6 or basically the end of the quarter. The TSX-V listing expenses will fall off. Human resources can be streamlined. They only need one CFO for instance
...more
(2244)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Aug 13, 2024 2:38pm
SGA history
The merged co. is distorting historical info by removing AEZS licensing fees and development services revenue from top line revenue and netting it against AEZS R&D and SG&A.
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
EnviroGold Global Announces Appointment of Chief Operating Officer
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed